Clinical trial: seven‐day vonoprazan‐ versus 14‐day proton pump inhibitor‐based triple therapy for first‐line <i>Helicobacter pylori</i> eradication-Reference-Cited by-同舟云学术

Clinical trial: seven‐day vonoprazan‐ versus 14‐day proton pump inhibitor‐based triple therapy for first‐line Helicobacter pylori eradication

Published:2022-06-03 Issue:3 Volume:56 Page:436-449
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Ang Daphne¹^ORCID,Koo Seok Hwee²,Chan Yiong Huak³,Tan Thean Yen⁴,Soon Gaik Hong²,Tan Chin Kimg¹,Lin Kenneth Weicong¹,Krishnasamy‐Balasubramanian Jaydeesh‐Khanna¹,Wong Yu Jun¹^ORCID,Kumar Rahul¹^ORCID,R Rajesh¹,Tan Yiyuan¹^ORCID,Ong Peng‐Lan Jeannie¹,Tan Yi‐Lyn Jessica¹,Li James Weiquan¹,Kwek Andrew Boon‐Eu¹,Ang Tiing Leong¹

Affiliation:

1. Department of Gastroenterology Changi General Hospital Singapore

2. Clinical Trials and Research Unit Changi General Hospital Singapore

3. Biostatistics Unit, Yong Yoo Lin School of Medicine National University of Singapore Singapore

4. Department of Laboratory Medicine Changi General Hospital Singapore

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17070

Reference65 articles.